Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary Bercu

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Schizophrenia Research|May 22, 2007
Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controlsMichael T Compton, Annie M Bollini, LaTasha McKenzie Mack, et al.
Canadian Journal of Gastroenterology & Hepatology|August 2, 2021
Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular CarcinomaAlexander Villalobos, William Wagstaff, Mian Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2023
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm studyNima Kokabi, Linzi Arndt-Webster, Bernard Chen, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 10, 2021
Percutaneous Management of Osteoarthritis in the Knee: Proceedings from the Society of Interventional Radiology Research Consensus PanelOsman Ahmed, Joel Block, Kenneth Mautner, et al.
Cardiovascular and Interventional Radiology|August 25, 2022
Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90)Richard Wu, Keerthi Gogineni, Jane Meisel, et al.
Cardiovascular and Interventional Radiology|November 24, 2020
Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched StudyLinzi Arndt, Alexander Villalobos, William Wagstaff, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Schizophrenia Research|May 22, 2007
Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controlsMichael T Compton, Annie M Bollini, LaTasha McKenzie Mack, et al.
Canadian Journal of Gastroenterology & Hepatology|August 2, 2021
Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular CarcinomaAlexander Villalobos, William Wagstaff, Mian Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2023
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm studyNima Kokabi, Linzi Arndt-Webster, Bernard Chen, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 10, 2021
Percutaneous Management of Osteoarthritis in the Knee: Proceedings from the Society of Interventional Radiology Research Consensus PanelOsman Ahmed, Joel Block, Kenneth Mautner, et al.
Cardiovascular and Interventional Radiology|August 25, 2022
Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90)Richard Wu, Keerthi Gogineni, Jane Meisel, et al.
Cardiovascular and Interventional Radiology|November 24, 2020
Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched StudyLinzi Arndt, Alexander Villalobos, William Wagstaff, et al.
Pageof 4